메뉴 건너뛰기




Volumn 115, Issue 5, 2005, Pages 1089-1090

COX-2-selective inhibitor valdecoxib induces severe allergic skin reactions [2]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRONE; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SULFONAMIDE; VALDECOXIB;

EID: 18144405761     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.12.1135     Document Type: Letter
Times cited : (9)

References (10)
  • 1
    • 5144221835 scopus 로고    scopus 로고
    • Lessons from the withdrawal of rofecoxib
    • P.A. Dieppe, S. Ebrahim, R.M. Martin, and P. Juni Lessons from the withdrawal of rofecoxib BMJ 329 2004 867 868
    • (2004) BMJ , vol.329 , pp. 867-868
    • Dieppe, P.A.1    Ebrahim, S.2    Martin, R.M.3    Juni, P.4
  • 2
    • 0038405018 scopus 로고    scopus 로고
    • Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
    • A. Szczeklik, and D.D. Stevenson Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management J Allergy Clin Immunol 111 2003 913 921
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 913-921
    • Szczeklik, A.1    Stevenson, D.D.2
  • 3
    • 0037902147 scopus 로고    scopus 로고
    • Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib: Results of oral provocation tests in patients with NSAID hypersensitivity
    • R. Kruse, T. Ruzicka, and M. Grewe Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib: results of oral provocation tests in patients with NSAID hypersensitivity Acta Derm Venereol 83 2003 183 185
    • (2003) Acta Derm Venereol , vol.83 , pp. 183-185
    • Kruse, R.1    Ruzicka, T.2    Grewe, M.3
  • 6
    • 0141991177 scopus 로고    scopus 로고
    • Safety of rofecoxib in nonsteroidal anti-inflammatory drugs intolerance
    • F.J. Munoz-Bellido, M. Terron, and A. Leon Safety of rofecoxib in nonsteroidal anti-inflammatory drugs intolerance Allergy 58 2003 1072 1075
    • (2003) Allergy , vol.58 , pp. 1072-1075
    • Munoz-Bellido, F.J.1    Terron, M.2    Leon, A.3
  • 7
    • 0037363538 scopus 로고    scopus 로고
    • Valdecoxib: A review
    • M.L. Chavez, and C.J. DeKorte Valdecoxib: a review Clin Ther 25 2003 817 851
    • (2003) Clin Ther , vol.25 , pp. 817-851
    • Chavez, M.L.1    Dekorte, C.J.2
  • 8
    • 1842844314 scopus 로고    scopus 로고
    • Cutaneous reaction to oral celecoxib with positive patch test
    • J.C. Alonso, J.D. Ortega, and M.J. Gonzalo Cutaneous reaction to oral celecoxib with positive patch test Contact Dermatitis 50 2004 48 49
    • (2004) Contact Dermatitis , vol.50 , pp. 48-49
    • Alonso, J.C.1    Ortega, J.D.2    Gonzalo, M.J.3
  • 9
    • 4444282446 scopus 로고    scopus 로고
    • Acute generalized exanthematic pustulosis: A case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far
    • B. Goeschke, and L.R. Braathen Acute generalized exanthematic pustulosis: a case and an overview of side effects affecting the skin caused by celecoxib and other COX-2 inhibitors reported so far Dermatology 209 2004 53 56
    • (2004) Dermatology , vol.209 , pp. 53-56
    • Goeschke, B.1    Braathen, L.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.